Evidence map›Paper›PMID 39843158›Full record

ArticleEuropean respiratory review : an official journal of the European Respiratory Society2025

Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review.

Anouk Delameillieure, Vivien Somogyi, Silja Schenk, Nur Toreyin, Nikola Stenzel, Liesbet Van Bulck, Sofie Breuls, Michael Kreuter, Wim A Wuyts, Nesrin Mogulkoc and 5 more

Abstract readScoping Review
In one paragraph

Article in European respiratory review : an official journal of the European Respiratory Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. mExperimental and therapeutic medicine · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anouk DelameillieureDept of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven - University of Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0003-1612-0317
Vivien SomogyiMainz Center for Pulmonary Medicine, Departments of Pneumology, Mainz University Medical Center, Mainz, Germany.
Silja SchenkDept of Psychology, Psychologische Hochschule Berlin (PHB), Berlin, Germany.
Nur ToreyinDept of Pulmonary Medicine, Ege University Medical School, Ege University Hospital, Izmir, Turkiye.
Nikola StenzelDept of Psychology, Psychologische Hochschule Berlin (PHB), Berlin, Germany.
Liesbet Van BulckDept of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven - University of Leuven, Leuven, Belgium.
Sofie BreulsDept of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven - University of Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0002-6474-6923
Michael KreuterMainz Center for Pulmonary Medicine, Departments of Pneumology, Mainz University Medical Center, Mainz, Germany.
Wim A WuytsUnit for Interstitial Lung Disease, Dept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-9648-3497
Nesrin MogulkocDept of Pulmonary Medicine, Ege University Medical School, Ege University Hospital, Izmir, Turkiye.
Jeanette BoydEuropean Lung Foundation (ELF), Sheffield, UK.
Steve JonesEuropean Pulmonary Fibrosis Federation (EU-PFF), Overijse, Belgium.
Liam GalvinEuropean Pulmonary Fibrosis Federation (EU-PFF), Overijse, Belgium.
Fabienne DobbelsDept of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven - University of Leuven, Leuven, Belgium fabienne.dobbels@kuleuven.be.
COCOS-IPF consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeople with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF) have a high symptom burden and a poor health-related quality of life (HRQoL). Despite efforts to offer specialised treatment, clinical care for these patients remains suboptimal and several nonmedical needs remain unaddressed. Developing a core outcome set (COS) can help to identify a minimum set of agreed-upon outcomes that should be measured and acted-upon in clinical care.

aimAs a first step towards developing a COS for IPF/PPF, we aimed to identify outcome domains investigated in IPF/PPF research.

methodsConducted within the COCOS-IPF (Co-designing a Core Outcome Set for and with patients with IPF) project, this scoping review follows Joanna Briggs Institute methodology and PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines to search PubMed, Embase and Web of Science for quantitative, qualitative and mixed-methods papers. We extracted each paper's outcomes verbatim and classified them using the COMET (Core Outcome Measures in Effectiveness Trials) taxonomy. Then, the research team structured outcomes or concepts with similar meanings inductively into outcome domains.

resultsWe included 428 papers, extracting 1685 outcomes. Most outcomes (n=1340) were identified in quantitative sources, which we could classify in 64 outcome domains, with the main domains being "all-cause survival" (n=237), "lung function" (n=164) and "exercise capacity" (n=99). Qualitative sources identified 51 outcome domains, with the most frequent being "capability to do activities you enjoy" (n=31), "anxiety, worry and fear" (n=26) and "dealing with disease progression" (n=25).

conclusionsThe identified outcomes, spanning diverse domains, highlight the complexity of patient experiences and can form the basis to develop a COS for IPF/PPF clinical care, as well as future research.

Indexed as

Endpoint DeterminationIdiopathic Pulmonary FibrosisLungPulmonary FibrosisDisease ProgressionHumansPredictive Value of TestsPrognosisQuality of LifeTreatment Outcome

Identifiers

PMID39843158
PMCPMC11751723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.